Clinical Trial Update: Liver Function Assessment - Feasibility and Dosing Study [NA]

View source ↗

Summary

A feasibility and dosing study for liver function assessment in hepatic failure was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Failure

Snippet

Sponsor: Cardiox Corporation | Conditions: Hepatic Failure | NA | Status: TERMINATED